{"schema_version":"alpha-profile-public-v1","slug":"gary-j-bridger-ph-d","canonical_url":"https://registry.alpha.ac/people/gary-j-bridger-ph-d","as_of":"2026-09-22T00:32:21.169068+00:00","published_at":"2026-09-02T02:37:20.545298+00:00","last_reviewed_at":"2026-05-16T03:29:31.078+00:00","identity":{"display_name":"Gary J. Bridger, Ph.D.","headshot_url":null,"headshot_media":null,"profile_kind":"director","role_tags":["director","executive"],"current_role":{"company_name":"X4 Pharmaceuticals, Inc","company_slug":"x4-pharmaceuticals-inc","exchange":"NASDAQ","ticker":"XFOR","role_category":"director","title":"Director","committee":null,"is_board_chair":false,"is_independent":true,"valid_from":"2018-01-01","valid_to":null,"is_current":true,"verification_status":"confirmed","confidence":0.85,"evidence":{"source_type":"sec_proxy","source_url":"https://www.sec.gov/Archives/edgar/data/1501697/000150169726000031/xfor-20260320.htm","effective_date":"2026-03-20","last_checked_at":"2026-04-25T00:23:00.668+00:00"}},"photo_match":null},"assurance":{"is_claimed":false,"status":"unverified","assurance_level":null,"method":null,"verified_at":null,"expires_at":null},"claiming":{"eligible":true,"label":"Is this you? Claim your Alpha Profile","claim_url":"https://terminal.alpha.ac/claim-profile?person=gary-j-bridger-ph-d","suggest_edit_label":"Suggest an edit","suggest_edit_url":"https://terminal.alpha.ac/claim-profile?person=gary-j-bridger-ph-d&mode=suggest","canonical_record_will_be_reused":true,"canonical_facts_owner_controlled":false},"presentation":{"schema_version":"alpha-profile-presentation-v1","state":"alpha_editorial","version":0,"published_at":null,"headline":null,"headline_evidence":null,"location":null,"photo":null,"cover":null,"about":["Dr. Bridger has extensive experience as an executive officer and director of several public and private life sciences companies. He served as Executive Vice President of Research and Development at Xenon Pharmaceuticals and Senior Vice President of Research and Development at Genzyme Corporation. He co-founded AnorMED Inc. in 1996 and currently serves as Interim Chief Scientific Officer at Liminal BioSciences Inc."],"links":[],"sources":[],"featured":[],"competencies":[],"board_preferences":null,"board_service":[{"organization":"X4 Pharmaceuticals, Inc","organizationId":"x4-pharmaceuticals-inc","title":"Director","period":"2018-01-01 · current","evidenceLabel":"sec_proxy","evidenceState":"verified","sourceUrl":"https://www.sec.gov/Archives/edgar/data/1501697/000150169726000031/xfor-20260320.htm"}],"experience":[],"education":[],"credentials":[],"section_order":null,"hidden_sections":[],"limitations":["Presentation fields do not alter independently verified Alpha Profile facts.","Owner-supplied résumé records retain their field-level evidence state.","Only confirmed company_person_roles with public evidence. Website governed_site_fallback rows are not invented. about/links are stored people.profile_summary/bio and linkedin_url only. Dates stay undisclosed when the role has no start_date. SoFi Bank is not SoFi Technologies."]},"presentation_authority":"confirmed_company_person_roles","roles":[{"company_name":"X4 Pharmaceuticals, Inc","company_slug":"x4-pharmaceuticals-inc","exchange":"NASDAQ","ticker":"XFOR","role_category":"director","title":"Director","committee":null,"is_board_chair":false,"is_independent":true,"valid_from":"2018-01-01","valid_to":null,"is_current":true,"verification_status":"confirmed","confidence":0.85,"evidence":{"source_type":"sec_proxy","source_url":"https://www.sec.gov/Archives/edgar/data/1501697/000150169726000031/xfor-20260320.htm","effective_date":"2026-03-20","last_checked_at":"2026-04-25T00:23:00.668+00:00"}}],"claims":[{"claim_type":"ai_ml_experience","claim_value":false,"claim_text":"Proxy extraction classified AI/ML experience for Gary J. Bridger, Ph.D. as false.","claim_state":"verified","valid_from":null,"valid_to":null,"confidence":0.72,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-16T03:29:31.300866+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"XFOR DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1501697/000150169726000031/xfor-20260320.htm","published_at":"2026-03-20T00:00:00+00:00","last_checked_at":"2026-05-16T03:29:31.161014+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"board_role","claim_value":"Director","claim_text":"Gary J. Bridger, Ph.D. currently serves as Director at X4 Pharmaceuticals, Inc.","claim_state":"verified","valid_from":"2026-03-20","valid_to":null,"confidence":0.92,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-16T03:29:31.251047+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"XFOR DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1501697/000150169726000031/xfor-20260320.htm","published_at":"2026-03-20T00:00:00+00:00","last_checked_at":"2026-05-16T03:29:31.161014+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"committee_assignments","claim_value":["Audit","Compensation"],"claim_text":"Gary J. Bridger, Ph.D. serves on Audit, Compensation.","claim_state":"verified","valid_from":"2026-03-20","valid_to":null,"confidence":0.88,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-16T03:29:31.273615+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"XFOR DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1501697/000150169726000031/xfor-20260320.htm","published_at":"2026-03-20T00:00:00+00:00","last_checked_at":"2026-05-16T03:29:31.161014+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"current_executive_company","claim_value":"Liminal BioSciences Inc.","claim_text":"Gary J. Bridger, Ph.D. is linked to Liminal BioSciences Inc. as an operating executive.","claim_state":"verified","valid_from":null,"valid_to":null,"confidence":0.85,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-16T03:29:31.426211+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"XFOR DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1501697/000150169726000031/xfor-20260320.htm","published_at":"2026-03-20T00:00:00+00:00","last_checked_at":"2026-05-16T03:29:31.161014+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"current_executive_role","claim_value":"Interim Chief Scientific Officer","claim_text":"Gary J. Bridger, Ph.D. is also listed as Interim Chief Scientific Officer.","claim_state":"verified","valid_from":null,"valid_to":null,"confidence":0.85,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-16T03:29:31.406088+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"XFOR DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1501697/000150169726000031/xfor-20260320.htm","published_at":"2026-03-20T00:00:00+00:00","last_checked_at":"2026-05-16T03:29:31.161014+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"cybersecurity_experience","claim_value":false,"claim_text":"Proxy extraction classified cybersecurity experience for Gary J. Bridger, Ph.D. as false.","claim_state":"verified","valid_from":null,"valid_to":null,"confidence":0.72,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-16T03:29:31.344953+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"XFOR DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1501697/000150169726000031/xfor-20260320.htm","published_at":"2026-03-20T00:00:00+00:00","last_checked_at":"2026-05-16T03:29:31.161014+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"technology_background","claim_value":false,"claim_text":"Proxy extraction classified technology background for Gary J. Bridger, Ph.D. as false.","claim_state":"verified","valid_from":null,"valid_to":null,"confidence":0.72,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-16T03:29:31.321763+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"XFOR DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1501697/000150169726000031/xfor-20260320.htm","published_at":"2026-03-20T00:00:00+00:00","last_checked_at":"2026-05-16T03:29:31.161014+00:00","relation":"supports","excerpt_locator":null}]},{"subject":"alpha:person:gary-j-bridger-ph-d","claim_type":"board_service","claim_value":{"tags":[],"title":"Director","period":"2018-01-01 · current","organization":"X4 Pharmaceuticals, Inc","organization_id":"x4-pharmaceuticals-inc"},"claim_text":"Director at X4 Pharmaceuticals, Inc (2018-01-01 · current)","valid_from":null,"valid_to":null,"verification_status":"confirmed","date_precision":"period_text_only","evidence":[{"source_url":"https://www.sec.gov/Archives/edgar/data/1501697/000150169726000031/xfor-20260320.htm","label":"sec_proxy","evidence_state":"verified"}],"claim_state":"confirmed","version":1}],"network":{"schema_version":"alpha-profile-network-public-v1","relationships":[],"relationship_pathfinding":false,"authentication_prompt":"Sign in to see how you're connected.","limitations":["Representative factual associations only.","Shared contexts do not assert personal acquaintance.","Anonymous graph traversal is not available."]},"permissions":{"classification":"open_public_projection","public_retrieval":true,"agent_retrieval":true,"redistribution":false,"model_training":false,"relationship_pathfinding":false,"direct_contact":false},"limitations":["Only permissioned public claims and evidence are included.","Absence of a claim is not evidence that the underlying fact is false.","Public retrieval does not grant model-training or redistribution rights.","Private relationships and Council activity are excluded."],"structured_data":{"@context":"https://schema.org","@type":"ProfilePage","@id":"https://registry.alpha.ac/people/gary-j-bridger-ph-d#profile","url":"https://registry.alpha.ac/people/gary-j-bridger-ph-d","dateModified":"2026-05-16T03:29:31.078+00:00","mainEntity":{"@type":"Person","@id":"https://registry.alpha.ac/people/gary-j-bridger-ph-d#person","name":"Gary J. Bridger, Ph.D.","url":"https://registry.alpha.ac/people/gary-j-bridger-ph-d","jobTitle":"Director","worksFor":{"@type":"Organization","name":"X4 Pharmaceuticals, Inc","tickerSymbol":"NASDAQ: XFOR"},"affiliation":[{"@type":"OrganizationRole","roleName":"Director","startDate":"2018-01-01","memberOf":{"@type":"Organization","name":"X4 Pharmaceuticals, Inc","url":"https://registry.alpha.ac/companies/x4-pharmaceuticals-inc","tickerSymbol":"NASDAQ: XFOR"}}]},"isBasedOn":[{"@type":"CreativeWork","url":"https://www.sec.gov/Archives/edgar/data/1501697/000150169726000031/xfor-20260320.htm","name":"XFOR DEF 14A director slate"}],"mainEntityOfPage":"https://registry.alpha.ac/people/gary-j-bridger-ph-d"},"trust":{"schema_version":"alpha-profile-trust-v1","verification":{"schema_version":"alpha-verification-states-v1","state":"source_reported","identity_ownership":"unclaimed","assurance_level":null,"claim_state_counts":{"source_reported":9,"corroborated":0,"alpha_verified":0,"disputed":0,"superseded":0},"derivation":"claim_states+identity_ownership","summary":"Published claims are reported by public sources; none is Alpha verified. Profile ownership is unclaimed."},"aggregation":{"schema_version":"alpha-claim-aggregation-v1","published_claim_count":9,"under_review_claim_count":0,"owner_supplied_claim_count":0,"evidence_record_count":3,"distinct_source_count":1,"conflicts":[],"conflict_count":0,"headline_conflict_count":0,"internal_review_conflict_count":0,"contradiction_types":[],"headline_conflict_types":[],"verification":{"schema_version":"alpha-verification-states-v1","state":"source_reported","identity_ownership":"unclaimed","assurance_level":null,"claim_state_counts":{"source_reported":9,"corroborated":0,"alpha_verified":0,"disputed":0,"superseded":0},"derivation":"claim_states+identity_ownership","summary":"Published claims are reported by public sources; none is Alpha verified. Profile ownership is unclaimed."},"coverage":{"schema_version":"alpha-coverage-metric-v1","published_claims":9,"corroborated_claims":0,"sources":3,"distinct_sources":1,"role_claims":1,"last_reviewed_at":"2026-05-16T03:29:31.078+00:00","observed_at":"2026-09-22T00:32:21.169068+00:00","freshness_days":129}},"rights":{"public_retrieval":"allowed","agent_retrieval":"allowed","redistribution":"not_granted","model_training":"not_granted","commercial_use":"not_specified","relationship_pathfinding":"not_granted","direct_contact":"not_granted"}},"projection":{"schema_version":"alpha-profile-projection-v5","entity":{"kind":"person","slug":"gary-j-bridger-ph-d","canonical_url":"https://registry.alpha.ac/people/gary-j-bridger-ph-d"},"publication":{"published_at":"2026-09-02T02:37:20.545298+00:00","last_reviewed_at":"2026-05-16T03:29:31.078+00:00","as_of":"2026-09-22T00:32:21.169068+00:00"},"representations":{"html":{"href":"https://registry.alpha.ac/people/gary-j-bridger-ph-d","media_type":"text/html"},"json":{"href":"https://registry.alpha.ac/api/public/profiles/gary-j-bridger-ph-d","media_type":"application/json"},"markdown":{"href":"https://registry.alpha.ac/people/gary-j-bridger-ph-d.md","media_type":"text/markdown"},"structured_data":{"embedded":true,"media_type":"application/ld+json"},"share_image":null},"permissions":{"public_retrieval":true,"agent_retrieval":true,"redistribution":false,"model_training":false,"relationship_pathfinding":false,"direct_contact":false}}}